First Time Loading...

Hisamitsu Pharmaceutical Co Inc
TSE:4530

Watchlist Manager
Hisamitsu Pharmaceutical Co Inc Logo
Hisamitsu Pharmaceutical Co Inc
TSE:4530
Watchlist
Price: 3 823 JPY 1.16%
Updated: Apr 30, 2024

Hisamitsu Pharmaceutical Co Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hisamitsu Pharmaceutical Co Inc
Revenue Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Hisamitsu Pharmaceutical Co Inc
TSE:4530
Revenue
¥139.3B
CAGR 3-Years
4%
CAGR 5-Years
0%
CAGR 10-Years
-1%
Takeda Pharmaceutical Co Ltd
TSE:4502
Revenue
¥4.2T
CAGR 3-Years
9%
CAGR 5-Years
19%
CAGR 10-Years
10%
Daiichi Sankyo Co Ltd
TSE:4568
Revenue
¥1.5T
CAGR 3-Years
16%
CAGR 5-Years
10%
CAGR 10-Years
4%
Otsuka Holdings Co Ltd
TSE:4578
Revenue
¥2T
CAGR 3-Years
12%
CAGR 5-Years
9%
CAGR 10-Years
4%
Chugai Pharmaceutical Co Ltd
TSE:4519
Revenue
¥1.1T
CAGR 3-Years
12%
CAGR 5-Years
14%
CAGR 10-Years
10%
Astellas Pharma Inc
TSE:4503
Revenue
¥1.9T
CAGR 3-Years
15%
CAGR 5-Years
8%
CAGR 10-Years
6%

See Also

What is Hisamitsu Pharmaceutical Co Inc's Revenue?
Revenue
139.3B JPY

Based on the financial report for Nov 30, 2023, Hisamitsu Pharmaceutical Co Inc's Revenue amounts to 139.3B JPY.

What is Hisamitsu Pharmaceutical Co Inc's Revenue growth rate?
Revenue CAGR 10Y
-1%

Over the last year, the Revenue growth was 11%. The average annual Revenue growth rates for Hisamitsu Pharmaceutical Co Inc have been 4% over the past three years , and -1% over the past ten years .